Greyson International, Inc. (Pink Sheets: GYSN) announced today that it has scheduled an investor conference call for February 20, 2013 at 4:15 pm EST. Greyson will be providing updates on: the development and entry into new product categories, the formation of our Bio-medical subsidiary, an update on Greyson’s energy assets, as well as an update on all aspects of Greyson’s business. Conference call specifics will be announced at a later date. Greyson International CEO Harvey Tauman, “Our company has made tremendous progress over the last several months and I’m looking forward to outlining these accomplishments as well as discuss our future plans in this call.” About Greyson International, Inc. Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International's Facebook page http://www.facebook.com/GreysonInternationalInc. This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.